When it comes to dose design and drug development, one size doesn’t fit all. At AustinPx, every formulation strategy is built around your molecule, your patient, and your goals.
As a sponsor-informed CDMO, AustinPx was founded on the belief that the right partnership accelerates innovation. We combine advanced science, clinical insight, and flexible manufacturing to help innovators overcome development barriers—faster and smarter.
Our team works side-by-side with you to gather and interpret the data that guides confident decisions at every stage of development. From discovery through scale-up, we’re committed to helping you build your solution—not just a product.
Our Expertise and Capabilities Include:
Join Us at BIO 2026
June 22-25, 2026
San Diego Convention Center
San Diego, CA
The BIO International Convention is the largest and most comprehensive event for biotechnology, representing the full ecosystem of biotech with 20,000 industry leaders from across the globe. BIO 2026 is where we return to this essential "why." It is our opportunity to reconnect as a global community, to recharge our commitment, and to remember that behind every innovation is a shared mission: to improve lives.
Reimagine your formulation strategy with a broader set of enhancement technologies for complex controlled release. Meet with AustinPx Senior Director of Business Development Collin Burger during BIO International Convention 2026.
Featured Expert Content
To review more Expert Content, please visit the AustinPx Knowledge Center.
Ready to Build?
Schedule a meeting with our team to see how AustinPx can help you move from molecule to market—efficiently and confidently.